Pharmacometabolomics Enables Real-World Drug Metabolism Sciences
<b>Background/Objectives</b>: Pharmacogenomics (PGx) has revolutionized personalized medicine, notably by predicting drug responses through the study of the metabolic genotype of drug-metabolizing enzymes. However, these genotypes rely heavily on the availability and completeness of drug...
Saved in:
Main Authors: | Fleur B. Nijdam, Marieke A. J. Hof, Hans Blokzijl, Stephan J. L. Bakker, Eelko Hak, Gérard Hopfgartner, Frank Klont, on behalf of the TransplantLines Investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/15/1/39 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity
by: Jaeseong Oh, et al.
Published: (2018-09-01) -
Analysis of depression in Brazil and the feasibility of incorporating pharmacogenomics as an auxiliary tool in antidepressant treatment
by: Rafaela Slaviero Pinheiro Cerdeira, et al.
Published: (2025-01-01) -
Stryphnodendron adstringens have a modulatory effect on inflammatory cytokines markers of in vitro activated macrophages
by: Ivana Beatrice Mânica da Cruz, et al.
Published: (2024-05-01) -
Pharmacogenomics Tools for Precision Public Health and Lessons for Low- and Middle-Income Countries: A Scoping Review
by: Borbón A, et al.
Published: (2025-01-01) -
Pharmacogenomic profiling of variants affecting efficacy and toxicity of anti-infective medicines in a south Asian population from Sri Lanka
by: Priyanga Ranasinghe, et al.
Published: (2025-02-01)